Abstract
In this issue of Blood, Xu-Monette et al show that CD37 protein expression is a strong prognostic marker in diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP.1 CD37 negativity is associated with poor outcome and a high prevalence of adverse genetic and biologic features.1
Cite
CITATION STYLE
APA
Bertoni, F., & Stathis, A. (2016, December 29). Staining the target: CD37 expression in lymphomas. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2016-11-748137
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free